All posts by: Michael Zand

About Michael Zand

It’s all about the (stem cell) neighborhood – EurekAlert (press release)

Continue reading

2018-04-06 NEWS

EurekAlert (press release)

It’s all about the (stem cell) neighborhood
EurekAlert (press release)
A team headed by Gedas Greicius and Professor David Virshup, Director of the Programme in Cancer & Stem Cell Biology in Duke-NUS Medical School, studied the source and functional role of Wnts and RSPO3 [1]. RSPO3 is by far the most abundant R-spondin
Mechanism vital to keeping blood stem cells functional uncoveredScience Codex
Why cells with identical genes perform unique jobs — ScienceDailyScience Daily

all 13 news articles »

Continue reading

2018-04-06 NEWS

EurekAlert (press release)

It’s all about the (stem cell) neighborhood
EurekAlert (press release)
Stems cells in our adult tissues live in very specific locations called stem cell niches. These niches provide a specialised, ideal neighbourhood for stem cells. The stem cells in the niche are undifferentiated, meaning they have not yet changed into a

and more »

Continue reading

2018-04-06 NEWS

STAT

Incyte’s cancer drug fails trial, marking major blow for immunotherapy combination treatment
STAT
he first real clinical test of the cancer immunotherapy combination thesis has come back negative. Incyte said Friday that its experimental drug epacadostat failed to improve the efficacy of Merck’s checkpoint inhibitor Keytruda when the two drugs were
Incyte tumbles after combo therapy with Merck fails studyCNBC
Incyte slumps 19% after combo therapy fails late-stage testFinancial Times
Incyte, Merck & Co. Halt Phase III Trial After Epacadostat/Keytruda Combination Fails in MelanomaGenetic Engineering & Biotechnology News
Benzinga –Business Insider Australia
all 146 news articles »
Continue reading

2018-04-06 NEWS

Medical breakthrough: Seattle man is first adult to get new gene therapy for vision
Bristol Herald Courier (press release) (blog)
So Willis checked in with his eye doctor late last year, setting in motion a train of events that culminated March 20 at Children’s Hospital Los Angeles (CHLA) when he became the first adult to undergo the first gene therapy approved in the U.S. for